p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy

doi:10.3748/wjg.v11.i36.5696

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 36

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2501)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

196

HTML

1998

Figures (1-2)

193

Tables (1-4)

114

Sum=2501

Sep 28, 2005 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Sep 28, 2005; 11(36): 5696-5700
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5696

p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy

Fumiko Sunada, Masayuki Itabashi, Hisanao Ohkura, Toshiyuki Okumura

Fumiko Sunada, Masayuki Itabashi, Hisanao Ohkura, Toshiyuki Okumura, Departments of Internal Medicine, Pathology, Radiology, Ibaraki Prefectural Central Hospital and Cancer Center, Koibuchi 6528, Tomobe-machi Nishiibaraki-gun, Ibaraki-ken, Japan

Author contributions: All authors contributed equally to the work.

Correspondence to: Fumiko Sunada, MD, Department of Internal Medicine, Jichi Medical School Hospital, Yakushiji 3311, Minamikawachi-machi, Kawachi-gun, Tochigi 329-0498, Japan. f-sunada@jichi.ac.jp

Telephone: +81-285-587348 Fax: +81-285-448297

Received: December 15, 2004
Revised: January 23, 2005
Accepted: January 26, 2005
Published online: September 28, 2005

Abstract

AIM: Esophageal squamous cell carcinoma is generally sensitive to chemoradiotherapy (CRT), but some cases are not. Using a retrospective analysis, we aimed to identify the predictors of the response by esophageal squamous cell carcinoma to definitive CRT.

METHODS: The intensities of expression of p53, Ki67, Bcl-2, Bax, cyclin D1, VEGF, CDC25B, and metallothionein (MT) were evaluated immunohistochemically in the biopsy specimens obtained before CRT, and the intensities of their expression were tested for correlations with the clinical effects of CRT.

RESULTS: The esophageal squamous cell carcinomas with negative p53, positive CDC25B, and negative MT expression were found to be significantly more sensitive to CRT. In addition, p53 positivity and CDC25B positivity respond well to CRT.

CONCLUSION: Esophageal squamous cell carcinomas with negative p53,positive CDC25B, and negative MT expressions respond well to CRT. Even with p53 positivity, if with CDC25B positivity, CRT can be expected.

Keywords: p53, CDC25B, Metallothionein, Chemoradiotherapy, Esophageal squamous cell carcinomas